"Archbold Medical Center is a four-hospital, three nursing-home health system with 540 patient beds. We employ more than 2,500 people and boast an outstanding medical staff of nearly 200 qualified physician specialists. Our flagship hospital, John D. Archbold Memorial Hospital, is a 264-bed hospital located in Thomasville, Georgia. Our system hospitals, also in Georgia, are Brooks County Hospital in Quitman, Grady General Hospital in Cairo, and Mitchell County Hospital in Camilla."

During the past decade, John D. Archbold Memorial Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John D. Archbold Memorial Hospital" #1 sponsor was "BeiGene" with 1 trials, followed by "Celcuity, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "John D. Archbold Memorial Hospital" are "Breast Cancer" (1 trials), "COVID-19" (1 trials), "COVID-19 Pulmonary Complications" (1 trials), "Follicular Lymphoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "John D. Archbold Memorial Hospital" in a lesser frequency.

Most popular intervention types in "John D. Archbold Memorial Hospital" are "Drug" (5 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fulvestrant" (2 trials), "Alpelisib" (1 trials), "Anastrozole" (1 trials), "CV-18C3" (1 trials) and "Gedatolisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "John D. Archbold Memorial Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "John D. Archbold Memorial Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in John D. Archbold Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in John D. Archbold Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".